Targeting Effector Memory T Cells with the Small Molecule Kv1.3 Blocker PAP-1 Suppresses Allergic Contact Dermatitis

This publication has 72 references indexed in Scilit:

• Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases
  Proceedings of the National Academy of Sciences, 2006
• Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
  Nature, 2006
• CD28^nullCD4⁺ T Cells – Characterization of an Effector Memory T‐Cell Population in Patients with Rheumatoid Arthritis
  Scandinavian Journal of Immunology, 2004
• Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late
  British Journal of Dermatology, 2004
• Differential Voltage-dependent K+ Channel Responses during Proliferation and Activation in Macrophages
  Journal of Biological Chemistry, 2003
• A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis
  Journal of the American Academy of Dermatology, 2002
• Modulation of Kv Channel Expression and Function by TCR and Costimulatory Signals during Peripheral CD4+ Lymphocyte Differentiation
  The Journal of Experimental Medicine, 2002
• Local lymph node assay with non-radioisotope alternative endpoints.
  The Journal of Toxicological Sciences, 2002
• Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
  Nature, 1999
• CD4+ T-cell memory, CD45R subsets and the persistence of antigen—a unifying concept
  Immunology Today, 1998